Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel K Crowley

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Clinical Endocrinology|October 12, 2013
When would I use medical therapies for the treatment of primary hyperparathyroidism?Rachel K Crowley, Neil J Gittoes
Expert Review of Endocrinology & Metabolism|October 7, 2018
Syndrome of inappropriate antidiuresisRachel K Crowley, C J Thompson
Clinical Endocrinology|March 5, 2016
Elevated PTH with normal serum calcium level: a structured approachRachel K Crowley, Neil J Gittoes
European Endocrinology|April 11, 2018
Management of Craniopharyngioma - Perspectives beyond Surgery and EndocrinologyRachel K Crowley, Christopher J Thompson
Journal of the Endocrine Society|April 19, 2021
Letter to the Editor from Martin-Grace and Crowley: "Myxedema Heart and Pseudotamponade"Julie Martin-Grace, Rachel K Crowley
Clinical Endocrinology|April 26, 2022
When and how to stop denosumab therapy in a patient with osteoporosisEirena L Goulden, Rachel K Crowley
Journal of Diabetes Science and Technology|August 29, 2023
Intentional Insulin Overdose Using an Insulin Pump Fill Cannula Function: Safety Concerns and Identification Challenges Associated With This Pump ManipulationRobert E Lyons, Rachel K Crowley, David Slattery
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 26, 2018
RESPONSE LETTERMohamed Ahmed, Malachi J McKenna, Rachel K Crowley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2017
DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERNMohamed Ahmed, Malachi J McKenna, Rachel K Crowley
Therapeutic Advances in Endocrinology and Metabolism|June 9, 2021
Should denosumab treatment for osteoporosis be continued indefinitely?Jane A Noble, Malachi J McKenna, Rachel K Crowley
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|October 12, 2013
When would I use medical therapies for the treatment of primary hyperparathyroidism?Rachel K Crowley, Neil J Gittoes
Expert Review of Endocrinology & Metabolism|October 7, 2018
Syndrome of inappropriate antidiuresisRachel K Crowley, C J Thompson
Clinical Endocrinology|March 5, 2016
Elevated PTH with normal serum calcium level: a structured approachRachel K Crowley, Neil J Gittoes
European Endocrinology|April 11, 2018
Management of Craniopharyngioma - Perspectives beyond Surgery and EndocrinologyRachel K Crowley, Christopher J Thompson
Journal of the Endocrine Society|April 19, 2021
Letter to the Editor from Martin-Grace and Crowley: "Myxedema Heart and Pseudotamponade"Julie Martin-Grace, Rachel K Crowley
Clinical Endocrinology|April 26, 2022
When and how to stop denosumab therapy in a patient with osteoporosisEirena L Goulden, Rachel K Crowley
Journal of Diabetes Science and Technology|August 29, 2023
Intentional Insulin Overdose Using an Insulin Pump Fill Cannula Function: Safety Concerns and Identification Challenges Associated With This Pump ManipulationRobert E Lyons, Rachel K Crowley, David Slattery
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 26, 2018
RESPONSE LETTERMohamed Ahmed, Malachi J McKenna, Rachel K Crowley
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2017
DIABETIC KETOACIDOSIS IN PATIENTS WITH TYPE 2 DIABETES RECENTLY COMMENCED ON SGLT-2 INHIBITORS: AN ONGOING CONCERNMohamed Ahmed, Malachi J McKenna, Rachel K Crowley
Therapeutic Advances in Endocrinology and Metabolism|June 9, 2021
Should denosumab treatment for osteoporosis be continued indefinitely?Jane A Noble, Malachi J McKenna, Rachel K Crowley
Pageof 8